Baxter International Inc (BAX): Total Liabilities
$13.95B
As of 2025-12-31
$13.61B
As of 2026-06-30
-14.6%
3-year compound annual growth
+4.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.95B | -25.6% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $18.76B | -5.3% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $19.81B | -11.5% | 2025-02-21, Balance as of period end |
| 2022-12-31 | $22.39B | -8.2% | 2024-02-08, Balance as of period end |
| 2021-12-31 | $24.40B | +116.1% | 2023-02-09, Balance as of period end |
| 2020-12-31 | $11.29B | +9.8% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $10.28B | n/a | 2021-02-11, Balance as of period end |
| 2019-06-30 | $9.70B | n/a | 2020-03-17, Balance as of period end |
| 2019-03-31 | $8.65B | n/a | 2020-03-17, Balance as of period end |
| 2018-12-31 | $7.85B | n/a | 2020-03-17, Balance as of period end |
| 2018-09-30 | $7.71B | n/a | 2020-03-17, Balance as of period end |
| 2018-06-30 | $7.69B | n/a | 2020-03-17, Balance as of period end |
| 2018-03-31 | $7.78B | n/a | 2020-03-17, Balance as of period end |
| 2017-12-31 | $8.00B | n/a | 2019-02-21, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Baxter International Inc (BAX) | 2025-12-31 | $13.95B | -25.6% |
| Solventum Corp (SOLV) | 2025-12-31 | $9.24B | -19.6% |
| ResMed Inc (RMD) | 2026-06-30 | $2.38B | +7.9% |
| 3M Co (MMM) | 2025-12-31 | $32.99B | -8.3% |
| Stryker Corp (SYK) | 2025-12-31 | $25.42B | +13.8% |
| Dexcom Inc (DXCM) | 2025-12-31 | $3.59B | -18.0% |
| Medline Inc. (MDLN) | 2025-12-31 | $19.20B | -1.3% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $1.02B | +17.0% |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $1.09B | +13.8% |
Compare BAX, SOLV, RMD, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗